Skip to main content
. 2021 Feb 4;176:1–12. doi: 10.1016/j.ijbiomac.2021.02.012

Fig. 3.

Fig. 3

Molecular models of the binding of SARS-CoV-2 3CLpro with kaempferol (A), luteolin (B), isorhamnetin (C) and wogonin (D), epigallocatechin-3-gallate (E), naringenin (F), and quercetin (G) shown as 3D diagrams.